A study of 320 surgical NSCLC tissues revealed that adenocarcinomas, especially epidermal growth factor receptor (EGFR) mutants, had higher expression of FRα compared to squamous-cell carcinomas. This evidence concerns the gene FOLR1 and non-small cell lung carcinoma.